2014

December 2014

• "Measurement reliability over the product lifecycle: The need for reference materials"
• Christopher A. Bravery
• Speaker, chair
• Informa, Cell Therapy Manufacturing
• Brussels, Belgium

•  "Characterising your Gene Therapy product and ensuring good assay development"
• Christopher A. Bravery
• Speaker, workshop
• Life sciences Informa: Gene Therapy Conference
• Brussels, Belgium

September 2014

• "Measurement reliability over the product lifecycle: The need for reference materials"
• Christopher A. Bravery
• Speaker, session chair
• IBC's 4th Annual: Cell Therapy Bioprocessing
• Arlington, VA

April 2014

• Evaluation the Safety of Stem Cell Therapies: A Regulatory View
• Christopher A. Bravery
• Speaker
• Symposium 2: Development and safety of stem cell therapies
• London, UK

• Quality Considerations for Technology Transfer
• Christopher A. Bravery
• Pre-conference workshop, session chair, speaker
• ISCT Annual meeting
• Paris, France

March 2014 

• Comparability: Managing process changes
• Christopher A. Bravery,
• Co-chair, speaker and panelist
• Challenges toward sound scientific regulations of cell therapy products
• Kyoto, Japan

February 2014

• Banks for cell therapy
• Christopher A Bravery, PhD
• Speaker
• Cell line development and engineering
• Vienna, Austria